SpineThera gets a potential suitor: The maker of OxyContin

A non-opioid painkiller being developed by Plymouth-based SpineThera Inc. has caught the eye of Purdue Pharma, the maker of OxyContin, which has signed a deal to give the Connecticut pharmaceutical company the exclusive option to acquire SpineThera. The companies announced the deal, which also includes granting worldwide rights for SpineThera's key SX600 drug to Stamford, Conn.-based Purdue, on Monday. Terms weren't disclosed. “We are committed to alleviating pain through new and innovative…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news